Tinker Sarah C, Broussard Cheryl S, Frey Meghan T, Gilboa Suzanne M
National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Mail Stop E-86, 1600 Clifton Road, Atlanta, GA, 30333, USA,
Matern Child Health J. 2015 May;19(5):1097-106. doi: 10.1007/s10995-014-1611-z.
Many prescription medications have limited information regarding safety for use during pregnancy. In order to inform research on safer medication use during pregnancy, we examined prescription medication use among women in the United States. We analyzed data from the 1999-2006 National Health and Nutrition Examination Survey (NHANES) to estimate the prevalence of prescription medication use in the past 30 days among pregnant women and non-pregnant women of childbearing age (15-44 years) and to ascertain the most commonly reported prescription medications by women in these groups. We assessed how the most commonly reported medications differed among groups defined by selected demographic characteristics, including age, race/ethnicity, and markers of socioeconomic status. Prescription medication use in the past 30 days was reported by 22 % of pregnant women and 47 % of non-pregnant women of childbearing age. The most commonly reported prescription medications by NHANES participants differed somewhat by pregnancy status; allergy and anti-infective medications were more common among pregnant women, while oral contraceptives were more common among non-pregnant women. Use of prescription medication for asthma and thyroid disorders was reported by both groups. Although prescription medication use in the previous 30 days was less common among pregnant women than non-pregnant women, its use was reported among almost 1 in 4 pregnant women. Many of the most common medications reported were for the treatment of chronic medical conditions. Given the potential impact of medications on the developing fetus, our data underscore the importance of understanding the safety of these medications during pregnancy.
许多处方药关于孕期使用安全性的信息有限。为了为孕期更安全用药的研究提供信息,我们调查了美国女性的处方药使用情况。我们分析了1999 - 2006年国家健康和营养检查调查(NHANES)的数据,以估计孕妇和育龄非孕妇(15 - 44岁)在过去30天内使用处方药的患病率,并确定这些群体中女性最常报告使用的处方药。我们评估了按选定人口统计学特征(包括年龄、种族/族裔和社会经济地位指标)定义的群体中最常报告的药物有何不同。22%的孕妇和47%的育龄非孕妇报告在过去30天内使用过处方药。NHANES参与者最常报告的处方药因怀孕状况而有所不同;过敏和抗感染药物在孕妇中更常见,而口服避孕药在非孕妇中更常见。两组都报告了用于哮喘和甲状腺疾病的处方药使用情况。尽管孕妇在过去30天内使用处方药的情况比非孕妇少,但几乎四分之一的孕妇报告使用过。报告的许多最常见药物用于治疗慢性疾病。鉴于药物对发育中胎儿的潜在影响,我们的数据强调了了解这些药物在孕期安全性的重要性。